Contact us
Back to top

HealthDay Now: FDA Rejects Advisory Board to Approve Alzheimer's Drug

In our latest HealthDay Now interview, Mabel Jong spoke to Dr. G. Caleb Alexander, a professor at Johns Hopkins who served on the FDA advisory committee that nearly unanimously advised against approving Biogen's new Alzheimer's drug. Dr. Alexander shared his thoughts on the drug's highly uncertain efficacy and discussed whether the FDA's reputation has been permanently damaged by the controversial approval of the drug.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: Experts Discuss Cost, Safety, & Efficacy of New Alzheimer's Drug

In our latest HealthDay Now interview, Dr. Anton Porsteinsson, a principal investigator for the Biogen aducanumab trial, and Dr. Ken Lin, a primary care physician, discuss the controversial new Alzheimer's drug and whether it will provide any benefit to patients, despite its highly uncertain efficacy and steep cost.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: Experts Weigh In On Alzheimer's Drug Controversy

In our latest HealthDay Now interview, Mabel Jong heard from experts with inside knowledge on the FDA's controversial approval of aducanumab.

First up is Dr. G. Caleb Alexander, a professor at Johns Hopkins who served on the FDA advisory committee that nearly unanimously advised against approving Biogen's controversial new Alzheimer's drug. Then, a conversation between Dr. Anton Porsteinsson, a principal investigator for the drug trial, and Dr. Ken Lin, a primary care physician who, like most clinicians surveyed in a new poll, has his concerns and has said he will not prescribe the new drug.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: Diabetes Care in 2021

The 2021 conference of the American Diabetes Association (ADA) has concluded. This year, the focus was on the pandemic and the many ways it affected people with diabetes.

In our latest HealthDay Now, Mabel Jong spoke with Dr. Robert Gabbay, the ADA's chief scientific and medical officer. Dr. Gabbay shared important takeaways from the meeting and addressed insulin prices and racial disparities in diabetes care.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: ASCO 2021 Highlights

In our latest HealthDay Now, Mabel Jong spoke with Dr. Lori Pierce, president of the American Society of Clinical Oncology and a cancer radiation specialist at the University of Michigan.

Dr. Pierce shared important takeaways from the recently concluded 2021 ASCO annual meeting and discussed why equity was the chosen theme this year.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: The State of Mental Health and Post-COVID Stress Disorder

Watch our latest HealthDay Now to hear about the state of mental health and why many people fear returning to their social and work lives.

HealthDay's Mabel Jong spoke to Dr. Vivian Pender, president of the American Psychiatric Association, and Sherry Amatenstein, a social worker and therapist who has been dealing with these anxieties herself.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: The Rural Doctor Shortage and More From the 2021 ACP Annual Meeting

Watch our latest HealthDay Now for a preview of the American College of Physicians Annual Meeting 2021, covering topics like the alarming shortage of primary care physicians, bringing basic health delivery needs to rural residents, and why the ACP will focus on privacy concerns at its conference.

HealthDay Now's Mabel Jong speaks with Dr. Jacqueline Fincher, president of the American College of Physicians and an internist in a rural community in Georgia.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: The Latest on the Johnson & Johnson COVID-19 Vaccine Investigation

Watch our latest HealthDay Now as we cover the latest on the Johnson & Johnson COVID-19 vaccine investigation. An independent advisory panel to the CDC is waiting on additional information before making recommendations on the use of the Johnson & Johnson COVID-19 vaccine after reports about rare blood clots.

Mabel Jong from our liveblog team speaks with Lynn Bahta, a member of the CDC's Advisory Committee on Immunization Practices (ACIP) and a clinical expert for vaccines at the Minnesota Department of Health.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

Most Popular

HealthDay Now: Cancer Experts Share Highlights From Two Conferences

HealthDay Now: Why the COVID-19 Vaccine is Safe for Kids and How Vaccine Myths Impact Families

HD Live!: COVID-19 and Flu Season — How to Lessen the Potential for a Twindemic

Latest

HealthDay Now: American Association for Cancer Research Annual Meeting 2021 Recap

HealthDay Now: The Latest on Multisystem Inflammatory Syndrome in Children (MIS-C)

HealthDay Now: Debunking Vaccine Myths, Plus What's Next for Vaccinated People

HD Live!: Racial Disparities During the COVID-19 Pandemic and the Vaccination Rollout

HD Live!: The Global COVID-19 Vaccination Rollout

HD Live!: An Interview With Andrei Doroshin of Philly Fighting Covid

HD Live!: COVID-19 Vaccine Rollout — An Interview With Dr. Michael Osterholm

HD Live!: The Latest on the COVID-19 Vaccines — An Interview With Dr. Paul Offit

HD Live!: The State of COVID-19 in the US and Its Toll on Healthcare Workers

HD Live!: An Interview With Dr. Anthony Fauci

HD Live!: American Heart Association Scientific Sessions 2020 Highlights

HD Live!: What Healthcare Could Look Like With a Trump or Biden Victory

HD Live!: IDWeek Meeting Wrap-Up

HD Live!: American Academy of Pediatrics Conference Wrap-Up